| Full of Articles |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Relationships > Sexuality > Why Do Women 'Tease?' |
|
Full of Articles - Why Do Women 'Tease?'
In order to understand what is really going on with this phenomenon we need to stop projecting our male perspective According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product s onto women. Actually this apparently annoying behaviour makes perfect sense when evaluated from the point of view ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in of a woman. One of the reasons that women engage in this ‘teasing‘ behaviour is because of their need to attract s lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. fficient interested males to serve as potential mate selections, or choices. The problem for a woman is that for mo here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe st of human history, sex all too often, meant a large investment of her reproductive availability, time, and energy d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro in the genes of that particular male. For this reason alone, it has always been critical for a woman to make a good ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc choice in the first place. Because of this biological reality many female mammals have evolved the tendency to rem easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi ain sexually unreceptive without at least the availability of choices. It becomes clear that the presence of choice nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically is important for some women to have their sexual receptivity triggered at all. Other women may be triggered by out and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ ight competition for sexual access, such as dating many men or even getting them fighting. Ever wonder why so many ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi omen like guys fighting over them? They can be sexual triggers for a woman and some of them consistently instigate ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a fights. Even with a highly desirable mate available, lack of sufficient choice can be sufficient for some women to dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod emain sexually unreceptive. Since the mere physical presence of males does not, on its own, provide a choice of ma cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin es for a female, it is the presence and availability of more than one interested male that triggers receptivity. So tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen what should a woman do if she has an interested suitor and is in this psychology? Obviously, she should draw in ot t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel ers to compete with him. Another reason that women engage in ‘teasing’ behaviour is because flirting is a sexual s ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust ill that has a useful purpose. However, this skill must be practiced just like any other, even if no mating results y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products from it. Women don’t actually set out to tease men. It just happens that attracting many men without mating with . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de hem is a sexual strategy that women have evolved to help them make the best of their biology. This behaviour evolve elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip because it is successful. The fact that it makes the unsuccessful suitors uncomfortable is biologically irrelevant tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Debt Consolidation For Non Homeowners - What's The Best Way To Consolidate My Debt? No Teletrack - No Credit Check - Payday Cash Advance Loans Promotional Article Writing 101 - Part One
|